The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct an interventional, one year, randomized, double
blind, placebo-controlled trial with Liraglutide in patients with type 2 diabetes (diabetes
duration of >6 months and <10 years, HbA1c <10%) to evaluate its effects on the peripheral
autonomic nervous system, as well as inflammatory markers, and measures of oxidative and
nitrosative stress.